2XIDEAS AG Halozyme Therapeutics, Inc. Transaction History

2XIDEAS AG portfolio value:

$8.95M
portfolio value

2XIDEAS AG quarter portfolio value change:

-10.14%
quarter

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -30.23% -98.14K shares -5.32M $39.54 226.47K
Q2 2022 share Increase 0.00% 324.61K shares 14.28M $44 324.61K